US funding cuts delay life-saving mRNA melanoma vaccines
A patient's remarkable recovery from incurable melanoma via an mRNA trial highlights the therapy's potential. Yet, US federal funding cuts of $500m threaten to stall progress, leaving thousands in the UK and US with 'no options left'.


